Evidence map›Paper›PMID 33981405›Full record

ArticleParkinson's disease2021

Impact of Progression of Parkinson's Disease on Swallowing Ability and Oral Environment.

George Umemoto, Shinsuke Fujioka, Yasuyuki Iwasa, Yoshie Ozaki, Kayoko Koga, Kazumi Nishimura, Yoshio Tsuboi

Open access · goldAbstract read
In one paragraph

Article in Parkinson's disease, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Observational
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

George UmemotoSwallowing Disorders Center, Fukuoka University Hospital, Fukuoka, Japan.ORCID https://orcid.org/0000-0002-8458-1329
Shinsuke FujiokaDepartment of Neurology, Faculty of Medicine, Fukuoka University, Fukuoka, Japan.ORCID https://orcid.org/0000-0001-9901-9008
Yasuyuki IwasaDepartment of Dentistry, Haradoi Hospital, Fukuoka, Japan.ORCID https://orcid.org/0000-0002-0691-6111
Yoshie OzakiMaruozaki Dental Clinic, Oita, Japan.ORCID https://orcid.org/0000-0001-5918-6952
Kayoko KogaDepartment of Home Care Nursing, School of Nursing, Faculty of Medicine, Fukuoka University, Fukuoka, Japan.ORCID https://orcid.org/0000-0001-8712-9963
Kazumi NishimuraJapanese Red Cross Kyushu International College of Nursing, Fukuoka, Japan.ORCID https://orcid.org/0000-0002-7977-6180
Yoshio TsuboiDepartment of Neurology, Faculty of Medicine, Fukuoka University, Fukuoka, Japan.ORCID https://orcid.org/0000-0002-6758-0981
Fukuoka University · JPFukuoka University Hospital · JPHaradoi Hospital · JPJapanese Red Cross Kyushu International College of Nursing · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study investigated the impact of the severity and treatment of Parkinson's disease (PD) on the swallowing ability and oral environment of patients. Swallowing dysfunction increases the aspiration risk and may lead to poor oral health among patients with PD. We investigated the influences of PD progression and drug treatment on the swallowing ability and oral environment using simple noninvasive screening measurements. We recruited 87 patients with PD (mean age, 71.9 ± 8.0 years; mean Hoehn and Yahr score, 2.9 ± 0.9). The PD condition was assessed in each patient using the unified Parkinson's disease rating scale (UPDRS) part III, diet type and oropharyngeal function using the swallowing disturbances questionnaire (SDQ), maximum bite force (MBF), tongue pressure (TP), and oral bacterial count (OBC). Levodopa equivalent daily dose (LEDD) was also calculated for 56 participants. Based on an SDQ score of ≥11, 29.5% of patients were dysphagic, but almost all were still on a regular diet. The SDQ score was positively correlated with disease duration (

Identifiers

PMID33981405
PMCPMC8088364
OpenAlexW3158664222

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.